Effects of botulinum toxin type A on expression of genes in keloid fibroblasts

Wang Xiaoxue1, Chen Xi, Xiao Zhibo

  • 1Second Affiliated Hospital of the Harbin Medical University, Harbin City, China.

Abstract

Insights

Botulinum toxin type A (BoNT-A) alters gene expression in keloid fibroblasts, downregulating key growth factors like TGF-β1 and VEGF. This finding offers insights into BoNT-A's mechanism for treating keloid scars.

Area of Science:

  • Dermatology and Molecular Biology

Background:

  • Keloid scars involve invasive fibroblast growth, a process influenced by various biological factors.
  • Botulinum toxin type A (BoNT-A) shows potential in inhibiting keloid invasive growth, but its molecular mechanisms require elucidation.

Purpose of the Study:

  • To investigate the impact of BoNT-A on the expression of genes associated with invasive growth in keloid fibroblasts.

Main Methods:

  • Microarray analysis was employed to assess messenger RNA expression profiles of 112 genes related to invasive growth in BoNT-A-treated keloid fibroblasts.
  • Quantitative real-time polymerase chain reaction (qRT-PCR) was utilized to validate the microarray findings.

Main Results:

  • BoNT-A treatment led to the upregulation of the S100A4 gene.
  • Conversely, BoNT-A downregulated the expression of TGF-β1, VEGF, MMP-1, and PDGFA genes in keloid fibroblasts.

Conclusions:

  • The observed alterations in S100A4, TGF-β1, VEGF, MMP-1, and PDGFA gene expression by BoNT-A provide valuable insights into its functional role.
  • These findings suggest potential novel therapeutic strategies for keloid scarring by targeting these specific genes.

Related Concept Videos

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
Bacterial Toxins01:12

Bacterial Toxins

Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...